Guideline: Screening for prostate cancer (Republic of Cyprus): Difference between revisions
From Beacon
(Created page with "{{forproviders}} {{forpolicymakers}} Go back to Republic of Cyprus page '''Primary purpose:''' To outline the risk assessment and recommended procedures for PSA testing to detect prostate cancer. '''Sponsor, manager or home institution:''' dataOwner::Ministry of Health and dataOwner:Health Insurance Organization. '''Type of information:''' This guideline provides risk percentages for prostate cancer based on PSA levels, along with screening recommendations...") |
m (Update categories.) |
||
| (9 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forproviders</span> <span style="display:none">forpolicymakers</span> | |||
<span style="display:none">republicofcypruscountry</span> | |||
Go back to [[Republic of Cyprus]] page | Go back to [[Republic of Cyprus]] page | ||
'''Primary purpose:''' To outline the risk assessment and recommended procedures for PSA testing to detect prostate cancer. | '''Primary purpose:''' To outline the risk assessment and recommended procedures for PSA testing to detect prostate cancer. | ||
'''Sponsor, manager or home institution:''' [[dataOwner::Ministry of Health]] and [[dataOwner:Health Insurance Organization]]. | '''Sponsor, manager or home institution:''' [[dataOwner::Ministry of Health]] and [[dataOwner::Health Insurance Organization]]. | ||
'''Type of information:''' This guideline provides risk percentages for prostate cancer based on PSA levels, along with screening recommendations considering age, race, family history, and other factors affecting PSA results. It also includes guidance on when to pursue further diagnostic procedures and highlights the importance of individualized patient-physician discussions. [[availableVariable::diagnosis]], [[availableVariable::medical procedures]], [[availableVariable::age]], [[availableVariable::screening]], [[availableVariable::check-up examinations]]. | '''Type of information:''' This guideline provides risk percentages for prostate cancer based on PSA levels, along with screening recommendations considering age, race, family history, and other factors affecting PSA results. It also includes guidance on when to pursue further diagnostic procedures and highlights the importance of individualized patient-physician discussions. [[availableVariable::diagnosis]], [[availableVariable::medical procedures]], [[availableVariable::age]], [[availableVariable::screening]], [[availableVariable::check-up examinations]]. | ||
'''Cancer Areas of Interest:''' [[hasCancerType::C60-C63: Male genitalia cancer]]. [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/ | '''Cancer Areas of Interest:''' [[hasCancerType::C60-C63: Male genitalia cancer]]. [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/3b7c3521a6e9a1bbc2257cf30028391c?OpenDocument Click here to learn more]. | ||
'''Access to information:''' [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/ | '''Access to information:''' [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/3b7c3521a6e9a1bbc2257cf30028391c?OpenDocument Click here to access]. | ||
<span style="display:none">Prostate</span> | |||
<span style="display:none">Testicles</span> | |||
<span style="display:none">Penis</span> | |||
<span style="display:none">dataOwner::Ministry of Health</span> | |||
<span style="display:none">dataOwner::Health Insurance Organization</span> | |||
<span style="display:none">availableVariable::diagnosis</span> | |||
<span style="display:none">availableVariable::medical procedures</span> | |||
<span style="display:none">availableVariable::age</span> | |||
<span style="display:none">availableVariable::screening</span> | |||
<span style="display:none">availableVariable::check-up examinations</span> | |||
<span style="display:none">isPracticeGuideline</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">Prostatic</span> | |||
<span style="display:none">Testicular</span> | |||
<span style="display:none">Penile</span> | |||
Latest revision as of 12:03, 14 December 2025
Go back to Republic of Cyprus page
Primary purpose: To outline the risk assessment and recommended procedures for PSA testing to detect prostate cancer.
Sponsor, manager or home institution: Ministry of Health and Health Insurance Organization.
Type of information: This guideline provides risk percentages for prostate cancer based on PSA levels, along with screening recommendations considering age, race, family history, and other factors affecting PSA results. It also includes guidance on when to pursue further diagnostic procedures and highlights the importance of individualized patient-physician discussions. diagnosis, medical procedures, age, screening, check-up examinations.
Cancer Areas of Interest: C60-C63: Male genitalia cancer. Click here to learn more.
Access to information: Click here to access.
